RADIOLOGICAL OR NUCLEAR MEDICAL COUNTERMEASURE PRODUCT DEVELOPMENT SUPPORT (PDS)

The National Institutes of Health is seeking proposals for the Radiological or Nuclear Medical Countermeasure Product Development Support (PDS) program. This Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle provides specialized support for developing medical countermeasures against radiological and nuclear threats. Managed under solicitation 75N93026R00005, the procurement falls under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences. The contract has a $135 million ceiling and a seven-year performance period from 2027 through 2034. Work will be performed in the United States, and the solicitation is full and open. The primary Request for Proposals (RFP) document includes the Statement of Work, reporting requirements, and administration details. Proposals are due by August 31, 2026, at 3:00 PM EDT. The program requires compliance with clinical trial regulations, human subject protection, and animal welfare standards to advance medical products through the development lifecycle. The NIH has issued a solicitation for the PDS program to support the development of medical countermeasures against radiological and nuclear threats. This IDIQ contract aims to advance products through various development stages to maintain a pipeline of interventions for radiation-related public health emergencies. A seven-year period of performance is projected to run from 2027 through 2034.